. 2017 Jul 22;40(10):855–869. doi: 10.1007/s40264-017-0572-8
© The Author(s) 2017
Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Fig. 3.
Core characteristics of the European Union (EU) pharmacovigilance system